Senti Biosciences is trading $0.32, up 5.43%, with no clear company-specific catalyst identified for September 15, 2026.

  • Recent disclosures involved a $2.0 million convertible-note tranche and a $2.5 million equity commitment tied to merger plans, both announced earlier in September.
  • The broader biotech sector and major indexes are declining, so sector or market weakness does not explain today’s gain.